Sens. Kennedy, Hyde-Smith Condemn FDA's Removal of Patient Safeguards Regarding Chemical Abortion Drug
February 19, 2022
February 19, 2022
MADISONVILLE, Louisiana, Feb. 19 -- Sen. John Kennedy, R-Louisiana, issued the following news release on Feb. 18, 2022:
Sen. John Kennedy (R-La.) today joined Sen. Cindy Hyde-Smith (R-Miss.), Rep. Bob Latta (R-Ohio) and more than 100 other lawmakers in writing to Commissioner of the Food and Drug Administration (FDA) Robert Califf to condemn the FDA's decision to permanently eliminate longstanding patient safeguards associated with the chemical abortion drug mifepristone, and t . . .
Sen. John Kennedy (R-La.) today joined Sen. Cindy Hyde-Smith (R-Miss.), Rep. Bob Latta (R-Ohio) and more than 100 other lawmakers in writing to Commissioner of the Food and Drug Administration (FDA) Robert Califf to condemn the FDA's decision to permanently eliminate longstanding patient safeguards associated with the chemical abortion drug mifepristone, and t . . .